Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Journal.
Press releases published on June 24, 2025
Pequena nação busca investidores em assuntos climáticos para se tornarem cidadãos e ajudarem a mudar o mundo
GlobeNewswire
·
June 24, 2025
AUCKLAND, Nova Zelândia, June 24, 2025 (GLOBE NEWSWIRE) -- "Não vamos ficar parados esperando que as ondas levem as nossas casas e a nossa infraestrutura", disse o líder da menor república do mundo, logo após a nação ter usado a COP29 como uma plataforma …
小國招攬氣候投資者成為公民，共創全球變革
GlobeNewswire
·
June 24, 2025
紐西蘭奧克蘭, June 24, 2025 (GLOBE NEWSWIRE) -- 「我們不會坐等浪潮沖毀家園及基礎建設」，全球最小共和國的領袖在該國以 COP29 為契機推出全球最創新的氣候韌性計劃後鄭重聲明。 諾魯總統 David Adeang 續說：「在世界仍在爭論氣候行動之際，我們必須主動出擊捍衛國家未來。」 作為由氣候變遷前線的發展中國家組成的「氣候脆弱國家論壇」(Climate Vulnerable Forum) 的成員，諾魯政府正敦促世界各地投資者加入這項不僅惠及本國而更造福全球的大膽方案。 …
小国瞄准气候投资者，以颁发公民身份吸引其助力推动世界变革
GlobeNewswire
·
June 24, 2025
新西兰奥克兰, June 24, 2025 (GLOBE NEWSWIRE) -- 世界最小共和国的领导人发表宣言称：“我们不会坐等海浪冲毁我们的家园和基础设施”。不久前，该国以第 29 届联合国气候大会 (COP29) 为平台启动了全球最具创新性的气候韧性计划。 瑙鲁总统 Nauru David Adeang 继续说道：“当世界还在讨论该采取何种行动应对气候变化时，我们必须率先采取积极举措，以确保国家的未来安全。” 作为由直面气候变化最前线的发展中国家组成的“易受气候影响脆弱国家论坛”(Climate …
Kleinstaat will Klimainvestoren als Bürger gewinnen, um die Welt zu verändern
GlobeNewswire
·
June 24, 2025
AUCKLAND, Neuseeland, June 24, 2025 (GLOBE NEWSWIRE) -- „Wir werden nicht abwarten, bis die Wellen unsere Häuser und Infrastruktur wegspülen“, erklärte der Staatschef der kleinsten Republik der Welt, kurz nachdem sein Land die COP29 als Startrampe für …
Pickleball Equipment Market to Hit $1,848.1 Million by 2032, at a CAGR of 14.8%, says Coherent Market Insights
GlobeNewswire
·
June 24, 2025
Burlingame, CA, June 24, 2025 (GLOBE NEWSWIRE) -- The pickleball equipment market is estimated to be valued at USD 702.9 Mn in 2025 and is expected to reach USD 1,848.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 14.8% from 2025 to 2032. …
First Atlantic Nickel Reports 366 Meters of 1.46% Nickel in Magnetic Concentrate From Third RPM Zone Step-Out Drill Hole, Opening Eastern Expansion Discovery Potential
GlobeNewswire
·
June 24, 2025
GRAND FALLS-WINDSOR, Newfoundland and Labrador, June 24, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce positive Davis Tube Recovery (DTR) metallurgical …
Matrixport Launches Industry-First "Daily Dual Currency" Product, Establishing a New Paradigm in Crypto Wealth Management
GlobeNewswire
·
June 24, 2025
Singapore, June 24, 2025 (GLOBE NEWSWIRE) -- Matrixport, a leading all-in-one crypto financial services platform, today announced its launch of the industry's first structured financial product—Daily Dual Currency (“Daily Dual-Ccy”). This product enhances …
VCI Global Launches QuantGold to Power the Next Era of Sovereign AI and Encrypted Data Monetization
GlobeNewswire
·
June 24, 2025
QuantGold Enables AI to Compute on Sensitive Data without Exposure – Backed by 120+ Encryption Patents and Already Deployed in 100+ Institutions Targeting an approximate US$400 Billion Market, QuantGold Offers Encrypted, Pay-Per-Use AI Compute to Unlock …
UAV (Drone) Market in U.S. to Reach $5,470.1 Million: Outlook, Trends, Drivers & Forecast to 2029
GlobeNewswire
·
June 24, 2025
Delray Beach, FL, June 24, 2025 (GLOBE NEWSWIRE) -- The report "US UAV (Drone) Market by Type [Fixed Wing, Rotary Wing, Hybrid], Platform (Civil …
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome
GlobeNewswire
·
June 24, 2025
ASHBURN, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug …
Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation
GlobeNewswire
·
June 24, 2025
--During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study; on average, enobosarm 3mg significantly reduced body …
Primech AI, a Subsidiary of Primech Holdings, Expands to the Hong Kong Market Through a Strategic Partnership with ReMining Ai Ltd.
GlobeNewswire
·
June 24, 2025
SINGAPORE, June 24, 2025 (GLOBE NEWSWIRE) -- Primech AI Pte. Ltd. (“Primech AI” or the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), today announced the signing of a strategic partnership with Hong Kong-based ReMining Ai Ltd to …
Matrixdock Expands Real-World Asset Tokenization to Include Silver, Platinum, and Palladium
GlobeNewswire
·
June 24, 2025
SINGAPORE, June 24, 2025 (GLOBE NEWSWIRE) -- Amid rising global demand for alternative precious metals, Matrixdock, the real-world asset (RWA) tokenization platform under the Matrixport Group, announces its strategic plan to expand beyond gold by …
Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics
GlobeNewswire
·
June 24, 2025
Vancouver, Canada, June 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
CURRENC and Galaxy Payroll Group Partner to Develop AI-Powered HR Solutions
GlobeNewswire
·
June 24, 2025
SINGAPORE, June 24, 2025 (GLOBE NEWSWIRE) -- CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced that it has entered a …
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
GlobeNewswire
·
June 24, 2025
RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start in prostate cancer anticipated in 2H 2025 SYDNEY and BUNDOORA, Australia, June 24, 2025 (GLOBE NEWSWIRE) …
SELLAS Life Sciences to be Added to Russell 3000® and Russell 2000® Indexes
GlobeNewswire
·
June 24, 2025
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference
GlobeNewswire
·
June 24, 2025
SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …
MindRank Announces Positive Phase 2b Results for AI-Designed Oral GLP-1 Receptor Agonist MDR-001 in Adults with Obesity or Overweight
GlobeNewswire
·
June 24, 2025
MDR-001 achieved statistically significant weight reductions of 8.2% to 10.3% at 24 weeks compared to 2.5% with placebo (p<0.00001), with up to 48.1% of participants achieving ≥10% weight loss. No treatment-related serious adverse events were reported. …
Tokyo Lifestyle Co., Ltd. to Open a New Directly-Operated Store in Hong Kong
GlobeNewswire
·
June 24, 2025
Tokyo, Japan, June 24, 2025 (GLOBE NEWSWIRE) -- Tokyo Lifestyle Co., Ltd. (“Tokyo Lifestyle” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, …